Effectiveness of therapy with recombinant human growth hormone (rhGH) in patients with hypoplastic left heart syndrome (HLHS) and short stature
Growth failure in patients with HLHS is likely multifactorial in origin, extending beyond the cardiac defect and its treatment. Short stature in this population warrants thorough evaluation, and in cases of confirmed GHD, rhGH therapy should be considered when feasible. Treatment decisions must be individualized, considering the patient's overall clinical condition and coexisting comorbidities.
Authors
- Dorota Roztoczyńska (ORCID: https://orcid.org/0000-0003-1754-0137)
- Anna Wędrychowicz (ORCID: https://orcid.org/0000-0003-0864-6810)
- Jerzy Starzyk (ORCID: https://orcid.org/0000-0002-4086-6525)
- Dominika Januś (ORCID: https://orcid.org/0000-0001-8817-6948)
- Magdalena Ossowska (ORCID: https://orcid.org/0000-0002-8122-5265)
- Aleksandra Furtak (ORCID: https://orcid.org/0000-0001-6527-940X)
- Karolina Komorkiewicz
Institutions
- Jagiellonian University (PL)
- Uniwersytecki Szpital Dziecięcy (PL)
Publication Details
- Journal
- Endokrynologia Polska
- Published
- 2025-09-25
- DOI
- https://doi.org/10.5603/ep.106211
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00